AXSM Competitors & Alternatives
Compare Axsome Therapeutics Inc with similar stocks in the same industry
Biotechnology
AXSM
Main Stock$233.35
Tradestie Score
58
Market Cap
$5.92B
Revenue Growth
0.6%
Analyst Upside
+18.5%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$264.48
|
$12.36B | 31.3 | 60 | Compare |
|
EXEL
Exelixis Inc
|
$55.62
|
$11.09B | 18.6 | 61 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.85
|
$10.76B | - | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$67.11
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$59.22
|
$10.53B | 42.5 | 65 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.10
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$82.64
|
$10.22B | - | 61 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$541.93
|
$10.01B | - | 64 | Compare |
|
TECH
Bio-Techne Corp.
|
$71.46
|
$9.33B | 101.9 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$88.00
|
$8.88B | 262.5 | 60 | Compare |
More AXSM Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry